Breaking News Instant updates and real-time market news.

GRUB

GrubHub

$45.78

-0.13 (-0.28%)

, AMZN

Amazon.com

$1,001.81

1.18 (0.12%)

08:15
07/17/17
07/17
08:15
07/17/17
08:15

GrubHub price target raised to $55 from $47 at Roth Capital

Roth Capital analyst Darren Aftahi raised his price target for GrubHub (GRUB) to $55 from $47 saying that despite Amazon's (AMZN) expansion into restaurant delivery, near-term risk may be overstated as only about 3.8% of his survey respondents use it in comparison to the former's 20.3% response rate. The analyst reiterates a Buy rating on the shares.

GRUB

GrubHub

$45.78

-0.13 (-0.28%)

AMZN

Amazon.com

$1,001.81

1.18 (0.12%)

  • 27

    Jul

  • 08

    Aug

GRUB GrubHub
$45.78

-0.13 (-0.28%)

06/26/17
MSCO
06/26/17
DOWNGRADE
MSCO
Equal Weight
GrubHub downgraded to Equal Weight on increasing competition at Morgan Stanley
As previously reported, Morgan Stanley downgraded GrubHub (GRUB) to Equal Weight from Overweight and lowered its price target to $43 from $47. Analyst John Glass' survey results indicate 26% of Amazon (AMZN) Prime members have tried Amazon Restaurants in the past 6 months, and other players such as UberEATS and YelpEat24 are emerging, which longer-term will reduce GrubHub's profitability and cash flow.
06/26/17
06/26/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. GrubHub (GRUB) downgraded to Equal Weight from Overweight by Morgan Stanley analyst John Glass, who lowered his price target to $43 from $47. The firm's survey results indicate 26% of Amazon (AMZN) Prime members have tried Amazon Restaurants in the past 6 months, and other players such as UberEATS and YelpEat24 are emerging, which longer-term will reduce GrubHub's profitability and cash flow, the analyst argues. 2. Stratasys (SSYS) downgraded to Sell from Neutral by Goldman Sachs analyst Matthew Cabral, who noted that the shares are up 67% year-to-date while competition is ramping and price pressure is mounting. 3. DaVita (DVA) downgraded to Hold from Buy by Jefferies analyst Chris Cooper, who cites slowing treatment growth and the "tight" rate environment. 4. Agios Pharmaceuticals (AGIO) downgraded to Neutral by Janney Capital analyst Debjit Chattopadhyay, who believes peak sales estimates for its acute myeloid leukemia treatment are likely to move lower over time. 5. American Electric (AEP) was downgraded to Neutral from Buy while Ameren (AEE) and WEC Energy (WEC) were both downgraded to Sell from Neutral at Goldman Sachs, where analyst Michael Lapides downgraded the Utilities sector to Cautious from Neutral saying valuations now appear stretched while earnings growth appears relatively normal. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/27/17
MONN
06/27/17
NO CHANGE
Target $32
MONN
Sell
GrubHub not likley to be takenout, says Monness Crespi
Monness Crespi said Grub does not have a defensible position in the restaurant network and with inferior logistics/dispatch capabilities, does not foresee a takeout of the company.
06/28/17
KEYB
06/28/17
NO CHANGE
KEYB
GrubHub should be bought on weakness, says KeyBanc
KeyBanc recommends buying GrubHub (GRUB) after the stock fell 9% so far this week. The firm blames the decline on fears of competition from Amazon (AMZN). However, it thinks that fears about Amazon "appear overdone," and notes that GrubHub's food delivery business is profitable. It keeps a $50 price target and Overweight rating on GrubHub.
AMZN Amazon.com
$1,001.81

1.18 (0.12%)

06/28/17
BARD
06/28/17
NO CHANGE
Target $200
BARD
Costco weakness a buying opportunity, says Baird
Baird analyst Peter Benedict said the recent pullback in Costco (COST) shares is a buying opportunity. He acknowledged the Amazon (AMZN) deal for Whole Foods (WFM) was a significant competitive development, but he believes Costco is well positioned to effectively compete in the evolving marketplace due to its superior quality/value equation, already thin margin profile, and a loyal member base. Benedict reiterated his Outperform rating and $200 price target on Costco shares.
06/28/17
OPCO
06/28/17
DOWNGRADE
OPCO
Perform
Whole Foods downgraded to Perform from Outperform at Oppenheimer
Oppenheimer analyst Rupesh Parikh downgraded Whole Foods (WFM) to Perform from Outperform, stating that while he believes Amazon's (AMZN) buyout price undervalues the company, it now appears less likely a strategic player will make a new bid.
06/30/17
RBCM
06/30/17
NO CHANGE
RBCM
Amazon.com lead over online competitors increasing, says RBC Capital
After RBC Capital conducted a survey of 2000 U.S. online shoppers, RBC Capital analyst Mark S.F. Mahaney says that a record 93% chose Amazon as their favorite online shopping site. Amazon had a 75 point lead on selection and a 68 point lead on convenience. He noted that only 7% have purchased groceries on Amazon but 13% plan to do so. Mahaney keeps a $1,100 price target and an Outperform rating on Amazon.
07/17/17
UBSW
07/17/17
NO CHANGE
Target $1200
UBSW
Buy
Amazon.com price target raised to $1,200 from $1,100 at UBS
UBS analyst Eric Sheridan raised his price target on Amazon.com to $1,200 from $1,100 to reflect its long-tailed opportunities, including Prime membership, which has increased shopping velocity among members. Sheridan, who reiterated his Buy rating on Amazon shares, also cites its advertising opportunity, cloud computing penetration, and third-party mix in its core retail operations.

TODAY'S FREE FLY STORIES

GPRO

GoPro

$9.08

-0.48 (-5.02%)

, CREE

Cree

$29.28

-0.08 (-0.27%)

07:30
10/17/17
10/17
07:30
10/17/17
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

GPRO

GoPro

$9.08

-0.48 (-5.02%)

CREE

Cree

$29.28

-0.08 (-0.27%)

MT

ArcelorMittal

$28.99

-0.36 (-1.23%)

PXD

Pioneer Natural

$143.69

-0.23 (-0.16%)

BABY

Natus Medical

$39.35

-0.75 (-1.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 25

    Oct

  • 01

    Nov

  • 02

    Nov

CARB

Carbonite

$22.30

-0.5 (-2.19%)

07:30
10/17/17
10/17
07:30
10/17/17
07:30
Initiation
Carbonite initiated  »

Carbonite initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

NEWS

NewStar Financial

$12.13

0.23 (1.93%)

07:30
10/17/17
10/17
07:30
10/17/17
07:30
Hot Stocks
Breaking Hot Stocks news story on NewStar Financial »

NewStar Financial trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JRVR

James River Group

$41.95

-0.08 (-0.19%)

07:27
10/17/17
10/17
07:27
10/17/17
07:27
Initiation
James River Group initiated  »

James River Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

MDB

MongoDB

07:27
10/17/17
10/17
07:27
10/17/17
07:27
Syndicate
MongoDB IPO deal range increased to $20.00-$22.00 »

MongoDB 's 8M share…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

NFLX

Netflix

$202.68

3.19 (1.60%)

07:26
10/17/17
10/17
07:26
10/17/17
07:26
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

PSX

Phillips 66

$90.87

-3.56 (-3.77%)

07:26
10/17/17
10/17
07:26
10/17/17
07:26
Recommendations
Phillips 66 analyst commentary  »

Phillips 66 price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

VZ

Verizon

$48.09

0.23 (0.48%)

07:25
10/17/17
10/17
07:25
10/17/17
07:25
Periodicals
Verizon FiOS stops carrying Univision, WSJ reports »

Verizon FiOS has stopped…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 01

    Nov

VLO

Valero

$77.42

-0.66 (-0.85%)

07:25
10/17/17
10/17
07:25
10/17/17
07:25
Recommendations
Valero analyst commentary  »

Valero price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

SNDX

Syndax

$12.76

0.39 (3.15%)

07:25
10/17/17
10/17
07:25
10/17/17
07:25
Syndicate
Syndax raises $25M in a registered direct offering »

Syndax announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMDZ

Immune Design

$10.10

-0.85 (-7.76%)

07:25
10/17/17
10/17
07:25
10/17/17
07:25
Conference/Events
Immune Design to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 08

    Nov

CVS

CVS Health

$72.44

-0.16 (-0.22%)

07:25
10/17/17
10/17
07:25
10/17/17
07:25
Conference/Events
Economic Club of New York to hold a breakfast meeting »

Larry Merlo, President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 20

    Oct

  • 06

    Nov

  • 12

    Dec

CVS

CVS Health

$72.44

-0.16 (-0.22%)

07:25
10/17/17
10/17
07:25
10/17/17
07:25
Conference/Events
Economic Club of New York to hold a breakfast meeting »

Larry Merlo, President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 20

    Oct

  • 06

    Nov

  • 12

    Dec

IPXL

Impax

$19.95

-0.85 (-4.09%)

07:24
10/17/17
10/17
07:24
10/17/17
07:24
Hot Stocks
Breaking Hot Stocks news story on Impax »

Impax trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

ANDV

Andeavor

$103.82

-1.55 (-1.47%)

07:24
10/17/17
10/17
07:24
10/17/17
07:24
Recommendations
Andeavor analyst commentary  »

Andeavor price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCMD

Tactile Systems

$30.87

-1.05 (-3.29%)

07:23
10/17/17
10/17
07:23
10/17/17
07:23
Initiation
Tactile Systems initiated  »

Tactile Systems initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

AGN

Allergan

07:22
10/17/17
10/17
07:22
10/17/17
07:22
Recommendations
Allergan analyst commentary  »

Allergan court ruling on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 23

    Oct

  • 01

    Nov

  • 06

    Nov

GRPN

Groupon

$4.70

0.07 (1.51%)

07:22
10/17/17
10/17
07:22
10/17/17
07:22
Initiation
Groupon initiated  »

Groupon initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 16

    Nov

FANG

Diamondback Energy

$102.60

1.23 (1.21%)

07:21
10/17/17
10/17
07:21
10/17/17
07:21
Recommendations
Diamondback Energy analyst commentary  »

Diamondback Energy price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

UNFI

United Natural Foods

$40.57

0.09 (0.22%)

, AMZN

Amazon.com

$1,006.34

3.4 (0.34%)

07:21
10/17/17
10/17
07:21
10/17/17
07:21
Downgrade
United Natural Foods, Amazon.com rating change  »

United Natural Foods…

UNFI

United Natural Foods

$40.57

0.09 (0.22%)

AMZN

Amazon.com

$1,006.34

3.4 (0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 26

    Oct

07:19
10/17/17
10/17
07:19
10/17/17
07:19
General news
Futures flat following yesterday's advance »

Stock futures are flat…

GM

General Motors

$45.76

-0.12 (-0.26%)

07:19
10/17/17
10/17
07:19
10/17/17
07:19
Periodicals
GM to test self-driving cars in NYC early next year, WSJ reports »

General Motors will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

WIT

Wipro

$5.46

-0.09 (-1.62%)

07:17
10/17/17
10/17
07:17
10/17/17
07:17
Earnings
Breaking Earnings news story on Wipro »

Wipro sees Q3 IT…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIT

Wipro

$5.46

-0.09 (-1.62%)

07:17
10/17/17
10/17
07:17
10/17/17
07:17
Earnings
Wipro reports Q2 revenue $2.1B, consensus $2.13B »

Reports Q2 net income…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$202.68

3.19 (1.60%)

07:16
10/17/17
10/17
07:16
10/17/17
07:16
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.